Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
830.9500
-0.55
(
-0.07
%)
NSE
Aug 12, 2025
15:31 PM
98.93% Gain from 52W Low
Volume:
1.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
30 Jan 2023
830.95
-0.07%
Synthesis/Non-ARV API drives earnings
Buy:
Laurus Labs Ltd.
by
Motilal Oswal
Target: 440
Target
Motilal Oswal
Laurus Labs Ltd. has gained
36.62%
in the last 6 Months
More from Laurus Labs Ltd.
Recommended
Market trades lower, Technocraft Industries' Q1 net profit declines 1.3% YoY to Rs 79.4 crore
Trendlyne Marketwatch |
12 Aug 2025, 03:34PM
IPO action stays active with four new issues and six listings this week
|
11 Aug 2025, 06:17PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020